Search
Sumario de resultados
TIpos de contenido
Fecha
-
EventWebinar: Metabolic Instability of Peptide Therapeutics: Mechanisms, Analytical Strategies,...
11am EST / 4pm GMT (UK) / 5pm CET (EU-Central).
-
EventWebinar: Accelerating Clinical Entry for Poorly Soluble Molecules
11am EST / 4pm GMT (UK) / 5pm CET (EU-Central).
-
CompanyELE Biotech
-
NewViva In Vitro appoints Professor Ignacio Martín-Loeches to its Medical Advisory Board, str...
Dr Ignacio Martín-Loeches joins Viva In Vitro Diagnostics as an advisor to its Medical Advisory Board, further strengthening a committee that already includes Dr Ricard Ferrer Roca (Vall d’Hebron
-
NewBCN HEALTH publishes a study highlighting the substantial productivity losses associated w...
Despite advances in oncology care, the persistently poor prognosis of pancreatic cancer and rising mortality rates have led to a sustained increase in productivity losses, particularly among the
-
NewThe need to promote entrepreneurship among young people
Youth entrepreneurship emerges as a natural response to a changing environment, where young people seek to transform ideas into real solutions and face social challenges with creativity, initiative
-
CompanyMOLEFY PHARMA
-
NewBiotechnology in the fight against cancer: from smart vectors to protein disorder as a the...
Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and safer targeted therapies, improving clinical outcomes and quality of life
-
Press releaseBiotechnology in the fight against cancer: from smart vectors to protein disorder as a the...
Biotechnology makes it possible to identify specific biomarkers and translate this knowledge into more effective and safer targeted therapies, improving clinical outcomes and quality of life
-
NewWhen genetics does not change, but science does. The challenge of keeping genetic health i...
A person's genetics do not change throughout their life. What does change, and does so constantly, is the scientific knowledge that allows us to interpret that information. This difference is forcing
-
NewORYZON strengthens patent portfolio for vafidemstat with new Decision to Grant in Japan
For the treatment of aggression and social withdrawal.
-
CompanyXENOPAT
-
NewNatac increases its EBITDA by 66.5% in 2025, surpassing €23 million
The figure is significantly above the €20 million previously forecast and communicated to the market
-
-
EventBioConnect 2026
-
-
NewBiotechnological innovation: key to healthier soils and resilient agricultural production
On the World Day of Action Against Global Warming, we highlight the strategic role of biotechnology in promoting more sustainable and resilient agricultural systems aligned with the EU’s climate
-
Press releaseBiotechnological innovation: key to healthier soils and resilient agricultural production
The EU has approved Directive (EU) 2025/2360 and the report EU Agricultural Outlook 2025–2035, establishing key soil health indicators and promoting more sustainable and efficient agricultural models
-
EventBIO EUROPE 2026
-
NewThe future of Clinical Trials
Digital transformation and artificial intelligence are redefining the traditional model of clinical trials.
-
NewArchivel Farma renews GMP certification and strengthens its transformation into a CDMO
The GMP renewal is the result of a comprehensive process to upgrade the facilities, manufacturing processes, and contamination control systems.